EV/EBIT Ratio: 18.39x
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 18.39x is 25% above its 5-year average of 14.72x, near the high end of its 5-year range (7.50x–20.46x).
As of Friday, June 26, 2026. 2.87% above its 12-month average of 17.88x.
DGX EV/EBIT Ratio Chart
DGX Average EV/EBIT Ratio Chart
DGX Current vs Average EV/EBIT Ratio Chart
DGX EV/EBIT Ratio Metrics
EV/EBIT RATIO
18.39x
EV/EBIT RATIO AVG TTM
17.88x
EV/EBIT RATIO AVG 3Y
17.63x
EV/EBIT RATIO AVG 5Y
14.72x
EV/EBIT RATIO AVG 10Y
14.60x
EV/EBIT RATIO AVG 15Y
13.28x
EV/EBIT RATIO AVG 20Y
12.64x
CURRENT VS TTM AVG
+2.87%
CURRENT VS 3Y AVG
+4.31%
CURRENT VS 5Y AVG
+24.95%
CURRENT VS 10Y AVG
+25.98%
CURRENT VS 15Y AVG
+38.51%
CURRENT VS 20Y AVG
+45.47%
DGX Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | 18.39x | 17.88x | 17.63x | 14.72x |
| BioNTech SE (BNTX)vs › | $22.76B | N/A | 4.91x | 5.85x | 5.85x |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 17.10x | 14.03x | 11.93x | 13.31x |
| Moderna, Inc. (MRNA)vs › | $23.71B | N/A | 23.08x | 30.95x | 30.95x |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 18.16x | 21.71x | 26.25x | 19.68x |
| Incyte Corporation (INCY)vs › | $21.48B | 12.97x | 18.39x | 111.47x | 74.87x |
| Waters Corporation (WAT)vs › | $24.57B | 56.01x | 28.67x | 26.95x | 26.42x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 23.92x | 26.02x | 26.23x | 29.11x |
| STERIS plc (STE)vs › | $20.52B | 20.30x | 26.21x | 35.18x | 52.85x |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 25.58x | 44.23x | 59.98x | 65.58x |
EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The EV/EBIT ratio for DGX stock is 18.39x.
- Is Quest Diagnostics Incorporated's EV/EBIT ratio high or low?
- The EV/EBIT ratio of 18.39x is 25% above its 5-year average of 14.72x, near the high end of its 5-year range (7.50x–20.46x).
- What is the TTM average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The TTM average EV/EBIT ratio for DGX stock is 17.88x.
- What is the 3Y average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The 3Y average EV/EBIT ratio for DGX stock is 17.63x.
- What is the 5Y average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The 5Y average EV/EBIT ratio for DGX stock is 14.72x.
- What is the 10Y average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The 10Y average EV/EBIT ratio for DGX stock is 14.60x.
- What is the 15Y average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The 15Y average EV/EBIT ratio for DGX stock is 13.28x.
- What is the 20Y average EV/EBIT ratio for Quest Diagnostics Incorporated (DGX)?
- The 20Y average EV/EBIT ratio for DGX stock is 12.64x.
DGX EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-25 | 18.39x |
| 2026-06-24 | 18.18x |
| 2026-06-23 | 17.76x |
| 2026-06-22 | 17.51x |
| 2026-06-18 | 17.61x |
| 2026-06-17 | 17.80x |
| 2026-06-16 | 18.03x |
| 2026-06-15 | 18.11x |
| 2026-06-12 | 18.17x |
| 2026-06-11 | 18.23x |
| 2026-06-10 | 18.22x |
| 2026-06-09 | 18.27x |
| 2026-06-08 | 17.77x |
| 2026-06-05 | 17.98x |
| 2026-06-04 | 17.69x |
| 2026-06-03 | 17.52x |
| 2026-06-02 | 17.49x |
| 2026-06-01 | 17.42x |
| 2026-05-29 | 17.61x |
| 2026-05-28 | 17.70x |
| 2026-05-27 | 17.54x |
| 2026-05-26 | 17.47x |
| 2026-05-22 | 17.63x |
| 2026-05-21 | 17.53x |
| 2026-05-20 | 17.53x |
| 2026-05-19 | 17.29x |
| 2026-05-18 | 17.25x |
| 2026-05-15 | 17.03x |
| 2026-05-14 | 17.12x |
| 2026-05-13 | 17.32x |
| 2026-05-12 | 17.28x |
| 2026-05-11 | 17.25x |
| 2026-05-08 | 17.08x |
| 2026-05-07 | 17.32x |
| 2026-05-06 | 17.21x |
| 2026-05-05 | 17.32x |
| 2026-05-04 | 17.37x |
| 2026-05-01 | 17.45x |
| 2026-04-30 | 17.56x |
| 2026-04-29 | 17.22x |
| 2026-04-28 | 17.62x |
| 2026-04-27 | 17.73x |
| 2026-04-24 | 17.70x |
| 2026-04-23 | 17.93x |
| 2026-04-22 | 18.24x |
| 2026-04-21 | 18.87x |
| 2026-04-20 | 18.25x |
| 2026-04-17 | 18.16x |
| 2026-04-16 | 17.90x |
| 2026-04-15 | 17.90x |
| 2026-04-14 | 18.09x |
| 2026-04-13 | 18.00x |
| 2026-04-10 | 17.90x |
| 2026-04-09 | 18.36x |
| 2026-04-08 | 18.43x |
| 2026-04-07 | 18.28x |
| 2026-04-06 | 18.44x |
| 2026-04-02 | 18.37x |
| 2026-04-01 | 18.35x |
| 2026-03-31 | 18.22x |
| 2026-03-30 | 18.31x |
| 2026-03-27 | 18.19x |
| 2026-03-26 | 18.38x |
| 2026-03-25 | 18.26x |
| 2026-03-24 | 18.23x |
| 2026-03-23 | 18.20x |
| 2026-03-20 | 18.17x |
| 2026-03-19 | 18.09x |
| 2026-03-18 | 18.17x |
| 2026-03-17 | 18.41x |
| 2026-03-16 | 18.44x |
| 2026-03-13 | 18.49x |
| 2026-03-12 | 18.58x |
| 2026-03-11 | 18.55x |
| 2026-03-10 | 18.58x |
| 2026-03-09 | 18.63x |
| 2026-03-06 | 18.46x |
| 2026-03-05 | 18.80x |
| 2026-03-04 | 19.12x |
| 2026-03-03 | 19.11x |
| 2026-03-02 | 19.25x |
| 2026-02-27 | 19.37x |
| 2026-02-26 | 19.31x |
| 2026-02-25 | 19.22x |
| 2026-02-24 | 19.35x |
| 2026-02-23 | 19.20x |
| 2026-02-20 | 18.83x |
| 2026-02-19 | 18.83x |
| 2026-02-18 | 18.97x |
| 2026-02-17 | 19.05x |
| 2026-02-13 | 19.16x |
| 2026-02-12 | 19.15x |
| 2026-02-11 | 19.34x |
| 2026-02-10 | 19.04x |
| 2026-02-09 | 18.00x |
| 2026-02-06 | 17.96x |
| 2026-02-05 | 18.08x |
| 2026-02-04 | 17.85x |
| 2026-02-03 | 17.55x |
| 2026-02-02 | 17.54x |
| 2026-01-30 | 17.69x |
| 2026-01-29 | 17.35x |
| 2026-01-28 | 17.37x |
| 2026-01-27 | 17.48x |
| 2026-01-26 | 17.36x |
| 2026-01-23 | 17.25x |
| 2026-01-22 | 17.33x |
| 2026-01-21 | 17.51x |
| 2026-01-20 | 17.83x |
| 2026-01-16 | 17.87x |
| 2026-01-15 | 17.93x |
| 2026-01-14 | 17.67x |
| 2026-01-13 | 17.17x |
| 2026-01-12 | 16.87x |
| 2026-01-09 | 16.76x |
| 2026-01-08 | 17.00x |
| 2026-01-07 | 17.03x |
| 2026-01-06 | 17.21x |
| 2026-01-05 | 16.69x |
| 2026-01-02 | 16.71x |
| 2025-12-31 | 16.69x |
| 2025-12-30 | 16.84x |
| 2025-12-29 | 16.84x |
| 2025-12-26 | 16.87x |
| 2025-12-24 | 16.87x |
| 2025-12-23 | 16.81x |
| 2025-12-22 | 16.90x |
| 2025-12-19 | 16.88x |
| 2025-12-18 | 16.89x |
| 2025-12-17 | 17.11x |
| 2025-12-16 | 17.07x |
| 2025-12-15 | 17.48x |
| 2025-12-12 | 17.36x |
| 2025-12-11 | 17.29x |
| 2025-12-10 | 17.14x |
| 2025-12-09 | 17.14x |
| 2025-12-08 | 17.31x |
| 2025-12-05 | 17.36x |
| 2025-12-04 | 17.48x |
| 2025-12-03 | 17.36x |
| 2025-12-02 | 17.36x |
| 2025-12-01 | 17.45x |
| 2025-11-28 | 17.85x |
| 2025-11-26 | 17.89x |
| 2025-11-25 | 18.08x |
| 2025-11-24 | 17.95x |
| 2025-11-21 | 18.00x |
| 2025-11-20 | 17.73x |
| 2025-11-19 | 17.61x |
| 2025-11-18 | 17.56x |
| 2025-11-17 | 17.63x |
| 2025-11-14 | 17.68x |
| 2025-11-13 | 17.73x |
| 2025-11-12 | 17.68x |
| 2025-11-11 | 17.82x |
| 2025-11-10 | 17.49x |
| 2025-11-07 | 17.13x |
| 2025-11-06 | 16.91x |
| 2025-11-05 | 17.04x |
| 2025-11-04 | 17.03x |
| 2025-11-03 | 17.09x |
| 2025-10-31 | 16.87x |
| 2025-10-30 | 16.86x |
| 2025-10-29 | 16.79x |
| 2025-10-28 | 17.04x |
| 2025-10-27 | 17.19x |
| 2025-10-24 | 17.33x |
| 2025-10-23 | 17.41x |
| 2025-10-22 | 17.26x |
| 2025-10-21 | 17.51x |
| 2025-10-20 | 18.70x |
| 2025-10-17 | 18.63x |
| 2025-10-16 | 18.42x |
| 2025-10-15 | 18.46x |
| 2025-10-14 | 18.31x |
| 2025-10-13 | 18.11x |
| 2025-10-10 | 18.21x |
| 2025-10-09 | 18.01x |
| 2025-10-08 | 17.97x |
| 2025-10-07 | 18.05x |
| 2025-10-06 | 17.78x |
| 2025-10-03 | 17.85x |
| 2025-10-02 | 17.98x |
| 2025-10-01 | 18.06x |
| 2025-09-30 | 18.71x |
| 2025-09-29 | 18.58x |
| 2025-09-26 | 18.59x |
| 2025-09-25 | 18.31x |
| 2025-09-24 | 18.42x |
| 2025-09-23 | 18.44x |
| 2025-09-22 | 18.26x |
| 2025-09-19 | 18.18x |
| 2025-09-18 | 18.16x |
| 2025-09-17 | 18.07x |
| 2025-09-16 | 17.91x |
| 2025-09-15 | 17.95x |
| 2025-09-12 | 18.12x |
| 2025-09-11 | 18.17x |
| 2025-09-10 | 17.91x |
| 2025-09-09 | 18.11x |
| 2025-09-08 | 18.10x |
| 2025-09-05 | 18.17x |
| 2025-09-04 | 17.91x |
| 2025-09-03 | 17.86x |
| 2025-09-02 | 17.80x |
| 2025-08-29 | 18.03x |
| 2025-08-28 | 17.84x |
| 2025-08-27 | 17.88x |
| 2025-08-26 | 17.93x |
| 2025-08-25 | 17.80x |
| 2025-08-22 | 17.92x |
| 2025-08-21 | 18.19x |
| 2025-08-20 | 18.24x |
| 2025-08-19 | 18.12x |
| 2025-08-18 | 17.82x |
| 2025-08-15 | 17.88x |
| 2025-08-14 | 17.78x |
| 2025-08-13 | 17.83x |
| 2025-08-12 | 17.80x |
| 2025-08-11 | 17.78x |
| 2025-08-08 | 17.67x |
| 2025-08-07 | 17.46x |
| 2025-08-06 | 17.37x |
| 2025-08-05 | 17.39x |
| 2025-08-04 | 17.32x |
| 2025-08-01 | 17.20x |
| 2025-07-31 | 16.94x |
| 2025-07-30 | 17.04x |
| 2025-07-29 | 16.98x |
| 2025-07-28 | 16.97x |
| 2025-07-25 | 17.02x |
| 2025-07-24 | 17.28x |
| 2025-07-23 | 17.17x |
| 2025-07-22 | 19.05x |
| 2025-07-21 | 18.10x |
| 2025-07-18 | 18.13x |
| 2025-07-17 | 18.24x |
| 2025-07-16 | 18.14x |
| 2025-07-15 | 18.09x |
| 2025-07-14 | 18.25x |
| 2025-07-11 | 18.23x |
| 2025-07-10 | 18.50x |
| 2025-07-09 | 18.68x |
| 2025-07-08 | 18.59x |
| 2025-07-07 | 18.71x |
| 2025-07-03 | 18.95x |
| 2025-07-02 | 18.92x |
| 2025-07-01 | 19.14x |
| 2025-06-30 | 19.17x |
| 2025-06-27 | 19.02x |
| 2025-06-26 | 18.96x |
| 2025-06-25 | 19.09x |
| 2025-06-24 | 19.19x |
| 2025-06-23 | 19.17x |
| 2025-06-20 | 19.15x |
| 2025-06-18 | 19.18x |
| 2025-06-17 | 19.11x |
| 2025-06-16 | 19.36x |
| 2025-06-13 | 19.21x |
| 2025-06-12 | 19.12x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis